PRODUCT USE IN COUNTRY WHERE PRODUCT IS UNAPPROVED

PRODUCT USE IN COUNTRY WHERE PRODUCT IS UNAPPROVED was reported 3 times

PRODUCT USE IN COUNTRY WHERE PRODUCT IS UNAPPROVED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Opioid Agonist [EPC] 1 0.0000
1 Kinase Inhibitor [EPC] 1 0.0000
2 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000